Mode
Text Size
Log in / Sign up

Intraductal papillary mucinous neoplasm of the bile duct

Part of Cancer

1 published article · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Cancer

Related studies from across the Cancer family.

Case report details multimodal treatment for aggressive thyroid carcinoma
Oncology Sys. Review
Case report details multimodal treatment for aggressive thyroid carcinoma First new treatment combination in six months stabilizes advanced thyroid cancer
A 61-year-old man with papillary thyroid carcinoma achieved disease stabilization after thyroidectomy, radiotherapy, and targeted therapy. T…
A 61-year-old man with advanced thyroid cancer saw his disease stop growing after a specific mix of treatments within six months of his diag…
Review of Mucinous cystic neoplasms of the liver with no reported outcomes or safety data
Orthopedics & Sports Medicine Sys. Review
Review of Mucinous cystic neoplasms of the liver with no reported outcomes or safety data Doctors now know how to safely remove rare liver cysts before they turn cancerous
This narrative review addresses Mucinous cystic neoplasms of the liver. No specific population, sample size, intervention, or outcomes were …
A new review explains how doctors can safely remove rare liver cysts before they turn into cancer
Trastuzumab emtansine and trastuzumab deruxtecan use in three patients with ERBB2-amplified rare tumors
Oncology Cohort
Trastuzumab emtansine and trastuzumab deruxtecan use in three patients with ERBB2-amplified rare tumors Rare tumors respond to targeted antibody drug treatments
This retrospective case series evaluated three patients with ERBB2-amplified rare tumors, including periampullary, salivary duct, and poorly…
Three patients with rare, aggressive cancers saw significant tumor shrinkage after receiving targeted antibody drug therapies.
Case report review of fertility-sparing surgery for ovarian borderline mucinous tumor with carcinosarcomatous mural nodule
Rheumatology Sys. Review
Case report review of fertility-sparing surgery for ovarian borderline mucinous tumor with carcinosarcomatous mural nodule A rare ovarian tumor diagnosis explained in a single patient case
This source is a case report review describing a 27-year-old female patient with an ovarian borderline mucinous tumor and carcinosarcomatous…
Doctors treated a 27-year-old woman with a rare ovarian tumor using fertility-sparing surgery and chemotherapy, with no signs of the cancer …
Case series describes four clear cell variant papillary thyroid carcinoma cases with NCOA4-RET fusions
Oncology Sys. Review
Case series describes four clear cell variant papillary thyroid carcinoma cases with NCOA4-RET fusions Rare Thyroid Cancer Has Unique Genetic Signature
This case series with literature review describes four pathologically confirmed cases of clear cell variant of papillary thyroid carcinoma d…
A rare thyroid cancer type may have a specific genetic cause that doctors can now look for.
Review highlights diagnostic challenges in testicular mucinous cystic neoplasm management
Oncology Sys. Review
Review highlights diagnostic challenges in testicular mucinous cystic neoplasm management A rare testicular cyst in an older man turned out to be a sign of hidden abdominal cancer
This case report and literature review describes a 78-year-old man who underwent scrotal exploration and right radical orchiectomy for a tes…
A rare testicular cyst in an older man turned out to be a sign of hidden abdominal cancer, highlighting the need for careful follow-up.
Savolitinib and durvalumab combination yields response rates of 34% to 53% in papillary renal cancer patients
Oncology Phase II
Savolitinib and durvalumab combination yields response rates of 34% to 53% in papillary renal cancer patients New Hope for a Tough Kidney Cancer Type
This single-arm phase II study evaluated savolitinib and durvalumab in 41 treatment-naïve or pretreated patients with papillary renal cancer…
A new drug pair breaks the shield blocking treatment for a rare kidney cancer type, offering patients a chance at longer survival after stan…
Autopsy study finds 55% thyroid nodular disease prevalence in Mexico City hospital patients
Neurology Cohort
Autopsy study finds 55% thyroid nodular disease prevalence in Mexico City hospital patients Autopsy study finds high thyroid nodule rates in Mexico City, no link to salt iodination
A retrospective cohort study of 487 autopsies from a third-level hospital in Mexico City found a thyroid nodular disease prevalence of 55% a…
Autopsies in Mexico City reveal thyroid nodules are very common, yet changing salt iodination rules did not increase their rates.
Combined CT morphological and histogram features improve differentiation of PIMA from PINMA compared to separate models
Radiology & Imaging Cohort
Combined CT morphological and histogram features improve differentiation of PIMA from PINMA compared to separate models Combining CT features improved lung cancer subtype prediction accuracy in a small review
This retrospective cohort review evaluated 163 patients with solitary pulmonary invasive mucinous adenocarcinoma (PIMA) or pulmonary invasiv…
Combining CT scan features boosts lung cancer subtype prediction accuracy to 0.845, offering a practical diagnostic aid for distinguishing b…